Advisor Group, Inc. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2019$16,000
+6.7%
150.0%0.00%
Q3 2019$15,000
-6.2%
150.0%0.00%
Q2 2019$16,000
-5.9%
150.0%0.00%
Q1 2019$17,000
+6.2%
150.0%0.00%
Q4 2018$16,000
-5.9%
15
+7.1%
0.00%
Q3 2018$17,0000.0%140.0%0.00%
Q2 2018$17,000
+30.8%
14
+16.7%
0.00%
Q1 2018$13,000
-7.1%
120.0%0.00%
Q4 2017$14,0000.0%120.0%0.00%
Q4 2016$14,0000.0%120.0%0.00%
Q3 2016$14,000
+7.7%
12
-7.7%
0.00%
Q2 2016$13,000130.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2017
NameSharesValueWeighting ↓
Birch Grove Capital LP 5,950,000$6,146,0004.56%
ADVENT CAPITAL MANAGEMENT /DE/ 37,943,000$39,192,0000.73%
Sonora Investment Management, LLC 4,670,000$4,791,0000.50%
MIZUHO SECURITIES USA LLC 5,900,000$6,096,0000.36%
IRON Financial LLC 430,000$446,0000.33%
RWC Asset Management LLP 7,300,000$7,528,0000.32%
Calamos Advisors LLC 49,525,000$51,243,0000.28%
EDMOND DE ROTHSCHILD HOLDING S.A. 5,777,000$5,977,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 5,721,000$5,896,0000.18%
Calamos Wealth Management LLC 1,240,000$1,283,0000.17%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders